-
1
-
-
0032189850
-
Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway
-
Brinkman K, ter Hofstede HJ, Burger DM, Smeitink JA, Koopmans PP. (1998) Adverse effects of reverse transcriptase inhibitors: mitochondrial. toxicity as common pathway. AIDS 12:1735-1744. (Pubitemid 28454438)
-
(1998)
AIDS
, vol.12
, Issue.14
, pp. 1735-1744
-
-
Brinkman, K.1
Ter Hofstede, H.J.M.2
Burger, D.M.3
Smeitink, J.A.M.4
Koopmans, P.P.5
-
2
-
-
78650697283
-
Stavudine. toxicity in women is the main reason for treatment change in a 3-year prospective cohort of adult patients started on first-line. antiretroviral treatment in Uganda
-
Castelnuovo B, Kiragga A, Kamya MR, Manabe Y (2011) Stavudine. toxicity in women is the main reason for treatment change in a 3-year prospective cohort of adult patients started on first-line. antiretroviral treatment in Uganda. J Acquir Immune Defic Syndr. 56:59-63.
-
(2011)
J Acquir Immune Defic Syndr.
, vol.56
, pp. 59-63
-
-
Castelnuovo, B.1
Kiragga, A.2
Kamya, M.R.3
Manabe, Y.4
-
3
-
-
33750368328
-
Peripheral insensate neuropathy - A tall problem for US adults?
-
DOI 10.1093/aje/kwj281
-
Cheng YJ, Gregg EW, Kahn HS, Williams DE, De Rekeneire N, Narayan KM (2006) Peripheral insensate neuropathy-a tall. problem for US adults? Am J Epidemiol 164:873-880. (Pubitemid 44627272)
-
(2006)
American Journal of Epidemiology
, vol.164
, Issue.9
, pp. 873-880
-
-
Cheng, Y.J.1
Gregg, E.W.2
Kahn, H.S.3
Williams, D.E.4
De Rekeneire, N.5
Narayan, K.M.V.6
-
4
-
-
68249102371
-
Age and height predict neuropathy. risk in patients with HIV prescribed stavudine
-
Cherry CL, Affandi JS, Imran D, Yunihastuti E, Smyth K, Vanar S, Kamarulzaman A, Price P (2009) Age and height predict neuropathy. risk in patients with HIV prescribed stavudine. Neurology. 73:315-320.
-
(2009)
Neurology.
, vol.73
, pp. 315-320
-
-
Cherry, C.L.1
Affandi, J.S.2
Imran, D.3
Yunihastuti, E.4
Smyth, K.5
Vanar, S.6
Kamarulzaman, A.7
Price, P.8
-
5
-
-
69849086171
-
Impact of prior. HAART use on clinical outcomes in a large Kenyan HIV treatment. program
-
Chung MH, Drake AL, Richardson BA, Reddy A, Thiga J, Sakr SR, Kiarie JN, Yowakim P, John-Stewart GC (2009) Impact of prior. HAART use on clinical outcomes in a large Kenyan HIV treatment. program. Curr HIV Res 7:441-446.
-
(2009)
Curr HIV Res
, vol.7
, pp. 441-446
-
-
Chung, M.H.1
Drake, A.L.2
Richardson, B.A.3
Reddy, A.4
Thiga, J.5
Sakr, S.R.6
Kiarie, J.N.7
Yowakim, P.8
John-Stewart, G.C.9
-
6
-
-
0037076029
-
Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients
-
DOI 10.1056/NEJMoa012035
-
Cote HC, Brumme ZL, Craib KJ, Alexander CS, Wynhoven B, Ting L, Wong H, Harris M, Harrigan PR, O'Shaughnessy MV, Montaner. JS (2002) Changes in mitochondrial DNA as a marker of nucleoside. toxicity in HIV-infected patients. N Engl J Med 346:811-820. (Pubitemid 34984654)
-
(2002)
New England Journal of Medicine
, vol.346
, Issue.11
, pp. 811-820
-
-
Cote, H.C.F.1
Brumme, Z.L.2
Craib, K.J.P.3
Alexander, C.S.4
Wynhoven, B.5
Ting, L.6
Wong, H.7
Harris, M.8
Richard Harrigan, P.9
O'Shaughnessy, M.V.10
Montaner, J.S.G.11
-
7
-
-
0035085983
-
Peripheral neuropathy and antiretroviral drugs
-
DOI 10.1046/j.1529-8027.2001.006001014.x
-
Dalakas MC (2001) Peripheral neuropathy and antiretroviral drugs. J. Peripher Nerv Syst 6:14-20. (Pubitemid 32240452)
-
(2001)
Journal of the Peripheral Nervous System
, vol.6
, Issue.1
, pp. 14-20
-
-
Dalakas, M.C.1
-
8
-
-
79959401882
-
Lactic. acidosis and symptomatic hyperlactataemia in a randomized trial. of first-line therapy in HIV-infected adults in South Africa
-
Dlamini J, Ledwaba L, Mokwena N, Mokhathi T, Orsega S, Tsoku M, Kowo H, Proschan M, Khabo P, Maja P, Hadigan C (2011) Lactic. acidosis and symptomatic hyperlactataemia in a randomized trial. of first-line therapy in HIV-infected adults in South Africa. Antivir. Ther 16:605-609.
-
(2011)
Antivir. Ther
, vol.16
, pp. 605-609
-
-
Dlamini, J.1
Ledwaba, L.2
Mokwena, N.3
Mokhathi, T.4
Orsega, S.5
Tsoku, M.6
Kowo, H.7
Proschan, M.8
Khabo, P.9
Maja, P.10
Hadigan, C.11
-
9
-
-
77952121864
-
Continued high. prevalence and adverse clinical impact of human immunodeficiency. virus-associated sensory neuropathy in the era of combination. antiretroviral therapy: The CHARTER Study
-
Ellis RJ, Rosario D, Clifford DB, McArthur JC, Simpson D, Alexander. T, Gelman BB, Vaida F, Collier A, Marra CM, Ances B, Atkinson. JH, Dworkin RH, Morgello S, Grant I (2010) Continued high. prevalence and adverse clinical impact of human immunodeficiency. virus-associated sensory neuropathy in the era of combination. antiretroviral therapy: the CHARTER Study. Arch Neurol. 67:552-558.
-
(2010)
Arch Neurol.
, vol.67
, pp. 552-558
-
-
Ellis, R.J.1
Rosario, D.2
Clifford, D.B.3
McArthur, J.C.4
Simpson, D.5
Alexander, T.6
Gelman, B.B.7
Vaida, F.8
Collier, A.9
Marra, C.M.10
Ances, B.11
Atkinson, J.H.12
Dworkin, R.H.13
Morgello, S.14
Grant, I.15
-
10
-
-
34147161191
-
Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda
-
DOI 10.1097/QAI.0b013e318033ffa1
-
Forna F, Liechty CA, Solberg P, Asiimwe F, Were W, Mermin J, Behumbiize P, Tong T, Brooks JT, Weidle PJ (2007) Clinical. toxicity of highly active antiretroviral therapy in a home-based. AIDS care program in rural Uganda. J Acquir Immune Defic. Syndr 44:456-462. (Pubitemid 46555382)
-
(2007)
Journal of Acquired Immune Deficiency Syndromes
, vol.44
, Issue.4
, pp. 456-462
-
-
Forna, F.1
Liechty, C.A.2
Solberg, P.3
Asiimwe, F.4
Were, W.5
Mermin, J.6
Behumbiize, P.7
Tong, T.8
Brooks, J.T.9
Weidle, P.J.10
-
11
-
-
34347343922
-
Antiretroviral durability and tolerability in HIV-infected adults living in urban Kenya
-
DOI 10.1097/QAI.0b013e318050d66c
-
Hawkins C, Achenbach C, Fryda W, Ngare D, Murphy R (2007). Antiretroviral durability and tolerability in HIV-infected adults. living in urban Kenya. J Acquir Immune Defic Syndr 45:304-310. (Pubitemid 47012377)
-
(2007)
Journal of Acquired Immune Deficiency Syndromes
, vol.45
, Issue.3
, pp. 304-310
-
-
Hawkins, C.1
Achenbach, C.2
Fryda, W.3
Ngare, D.4
Murphy, R.5
-
12
-
-
24144487126
-
Management of HIV-1 infection with a combination of nevirapine, stavudine, and lamivudine: A preliminary report on the Nigerian antiretroviral program
-
DOI 10.1097/01.qai.0000159516.39982.1b
-
Idigbe EO, Adewole TA, Eisen G, Kanki P, Odunukwe NN, Onwujekwe. DI, Audu RA, Araoyinbo ID, Onyewuche JI, Salu OB, Adedoyin. JA, Musa AZ (2005) Management of HIV-1 infection with a combination. of nevirapine, stavudine, and lamivudine: a preliminary. report on the Nigerian antiretroviral program. J Acquir Immune. Defic Syndr 40:65-69. (Pubitemid 41233207)
-
(2005)
Journal of Acquired Immune Deficiency Syndromes
, vol.40
, Issue.1
, pp. 65-69
-
-
Idigbe, E.O.1
Adewole, T.A.2
Eisen, G.3
Kanki, P.4
Odunukwe, N.N.5
Onwujekwe, D.I.6
Audu, R.A.7
Araoyinbo, I.D.8
Onyewuche, J.I.9
Salu, O.B.10
Adedoyin, J.A.11
Musa, A.Z.12
-
13
-
-
80054857035
-
Comparative tolerability and efficacy of stavudine. 30 mg versus stavudine 40 mg in patients on combination antiretroviral. therapy in Kenya
-
Karara MW, Okalebo FA, Oluka MN, Ombega J, Guantai AN, Osanjo. GO (2010) Comparative tolerability and efficacy of stavudine. 30 mg versus stavudine 40 mg in patients on combination antiretroviral. therapy in Kenya. J AIDS HIV Res 2:24-31.
-
(2010)
J AIDS HIV Res
, vol.2
, pp. 24-31
-
-
Karara, M.W.1
Okalebo, F.A.2
Oluka, M.N.3
Ombega, J.4
Guantai, A.N.5
Osanjo, G.O.6
-
14
-
-
3042698158
-
Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial
-
DOI 10.1016/S0140-6736(04)16586-0, PII S0140673604165860
-
Laurent C, Kouanfack C, Koulla-Shiro S, Nkoue N, Bourgeois A, Calmy A, Lactuock B, Nzeusseu V, Mougnutou R, Peytavin G, Liegeois F, Nerrienet E, Tardy M, Peeters M, Andrieux-Meyer I, Zekeng L, Kazatchkine M, Mpoudi-Ngole E, Delaporte E (2004). Effectiveness and safety of a generic fixed-dose combination of. nevirapine, stavudine, and lamivudine in HIV-1-infected adults in. Cameroon: open-label multicentre trial. Lancet 364:29-34. (Pubitemid 38968622)
-
(2004)
Lancet
, vol.364
, Issue.9428
, pp. 29-34
-
-
Laurent, C.1
Kouanfack, C.2
Koulla-Shiro, P.S.3
Nkoue, N.4
Bourgeois, A.5
Calmy, A.6
Lactuock, B.7
Nzeusseu, V.8
Mougnutou, R.9
Peytavin, G.10
Liegeois, F.11
Nerrienet, E.12
Tardy, M.13
Peeters, M.14
Andrieux-Meyer, I.15
Zekeng, L.16
Kazatchkine, P.M.17
Mpoudi-Ngole, E.18
Delaporte, P.E.19
-
15
-
-
41449116953
-
Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon
-
DOI 10.1089/aid.2007.0219
-
Laurent C, Bourgeois A, Mpoudi-Ngole E, Ciaffi L, Kouanfack C, Mougnutou R, Nkoue N, Calmy A, Koulla-Shiro S, Delaporte E. (2008) Tolerability and effectiveness of first-line regimens combining. nevirapine and lamivudine plus zidovudine or stavudine in. Cameroon. AIDS Res Hum Retroviruses 24:393-399. (Pubitemid 351457754)
-
(2008)
AIDS Research and Human Retroviruses
, vol.24
, Issue.3
, pp. 393-399
-
-
Laurent, C.1
Bourgeois, A.2
Mpoudi-Ngole, E.3
Ciaffi, L.4
Kouanfack, C.5
Mougnutou, R.6
Nkoue, N.7
Calmy, A.8
Koulla-Shiro, S.9
Delaporte, E.10
-
16
-
-
11144243979
-
Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort
-
DOI 10.1086/426076
-
Lichtenstein KA, Armon C, Baron A, Moorman AC, Wood KC, Holmberg SD (2005) Modification of the incidence of drugassociated. symmetrical peripheral neuropathy by host and disease. factors in the HIVoutpatient study cohort. Clin Infect Dis 40:148-157. (Pubitemid 40053473)
-
(2005)
Clinical Infectious Diseases
, vol.40
, Issue.1
, pp. 148-157
-
-
Lichtenstein, K.A.1
Armon, C.2
Baron, A.3
Moorman, A.C.4
Wood, K.C.5
Holmberg, S.D.6
-
17
-
-
39049103024
-
3 does not increase incidence or risk of peripheral neuropathy, anemia, or renal insufficiency
-
DOI 10.1097/QAI.0b013e31815acacc, PII 0012633420080101000003
-
Lichtenstein KA, Armon C, Buchacz K, Chmiel JS, Moorman AC, Wood KC, Holmberg SD, Brooks JT (2008) Initiation of antiretroviral. therapy at CD4 cell counts >/0350 cells/mm3 does not. increase incidence or risk of peripheral neuropathy, anemia, or. renal insufficiency. J Acquir Immune Defic Syndr 47:27-35. (Pubitemid 351619366)
-
(2008)
Journal of Acquired Immune Deficiency Syndromes
, vol.47
, Issue.1
, pp. 27-35
-
-
Lichtenstein, K.A.1
Armon, C.2
Buchacz, K.3
Chmiel, J.S.4
Moorman, A.C.5
Wood, K.C.6
Holmberg, S.D.7
Brooks, J.T.8
-
18
-
-
0032412213
-
Peripheral neuropathy with nucleoside antiretrovirals. Risk factors, incidence and management
-
DOI 10.2165/00002018-199819060-00005
-
Moyle GJ, Sadler M (1998) Peripheral neuropathy with nucleoside. antiretrovirals: risk factors, incidence and management. Drug Saf. 19:481-494. (Pubitemid 29015407)
-
(1998)
Drug Safety
, vol.19
, Issue.6
, pp. 481-494
-
-
Moyle, G.J.1
Sadler, M.2
-
19
-
-
60549083974
-
Benefits and risks of stavudine. therapy for HIV-associated neurologic complications in Uganda
-
Sacktor N, Nakasujja N, Skolasky RL, Robertson K, Musisi S, Ronald. A, Katabira E, Clifford DB (2009) Benefits and risks of stavudine. therapy for HIV-associated neurologic complications in Uganda. Neurology 72:165-170.
-
(2009)
Neurology
, vol.72
, pp. 165-170
-
-
Sacktor, N.1
Nakasujja, N.2
Skolasky, R.L.3
Robertson, K.4
Musisi, S.5
Ronald, A.6
Katabira, E.7
Clifford, D.B.8
-
20
-
-
0036226083
-
Stavudine-associated peripheral neuropathy in zidovudine-naïve patients: Effect of stavudine exposure and antiretroviral experience
-
Scarsella A, Coodley G, Shalit P, Anderson R, Fisher RL, Liao Q, Ross. LL, Hernandez JE (2002) Stavudine-associated peripheral neuropathy. in zidovudine-naive patients: effect of stavudine exposure. and antiretroviral experience. Adv Ther 19:1-8. (Pubitemid 34438982)
-
(2002)
Advances in Therapy
, vol.19
, Issue.1
, pp. 1-8
-
-
Scarsella, A.1
Coodley, G.2
Shalit, P.3
Anderson, R.4
Fisher, R.L.5
Liao, Q.6
Ross, L.L.7
Hernandez, J.E.8
-
21
-
-
0029030096
-
Nucleoside analogue-associated peripheral. neuropathy in human immunodeficiency virus infection
-
Simpson DM, Tagliati M (1995) Nucleoside analogue-associated peripheral. neuropathy in human immunodeficiency virus infection. J. Acquir Immune Defic Syndr Hum Retrovirol 9:153-161.
-
(1995)
J. Acquir Immune Defic Syndr Hum Retrovirol
, vol.9
, pp. 153-161
-
-
Simpson, D.M.1
Tagliati, M.2
-
22
-
-
79953882406
-
HIV neuropathy. risk factors and symptom characterization in stavudineexposed. South Africans
-
Wadley AL, Cherry CL, Price P, Kamerman PR (2011) HIV neuropathy. risk factors and symptom characterization in stavudineexposed. South Africans. J Pain Symptom Manage 41:700-706.
-
(2011)
J Pain Symptom Manage
, vol.41
, pp. 700-706
-
-
Wadley, A.L.1
Cherry, C.L.2
Price, P.3
Kamerman, P.R.4
-
23
-
-
1942537798
-
Symptomatic distal sensory polyneuropathy in HIV after age 50
-
Watters MR, Poff PW, Shiramizu BT, Holck PS, Fast KM, Shikuma. CM, Valcour VG (2004) Symptomatic distal sensory polyneuropathy. in HIV after age 50. Neurology 62:1378-1383. (Pubitemid 38526052)
-
(2004)
Neurology
, vol.62
, Issue.8
, pp. 1378-1383
-
-
Watters, M.R.1
Poff, P.W.2
Shiramizu, B.T.3
Holck, P.S.4
Fast, K.M.S.5
Shikuma, C.M.6
Valcour, V.G.7
-
24
-
-
37349070983
-
Higher-than-expected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswana: Preliminary results from a large randomized clinical trial
-
DOI 10.1097/QAI.0b013e3181568e3f, PII 0012633420071101000010
-
Wester CW, Okezie OA, Thomas AM, Bussmann H, Moyo S, Muzenda T, Makhema J, van Widenfelt E, Musonda R, Novitsky. V, Gaolathe T, Ndwapi N, Essex M, Kuritzkes DR, DeGruttola V, Marlink RG (2007) Higher-than-expected rates of lactic acidosis. among highly active antiretroviral therapy-treated women in. Botswana: preliminary results from a large randomized clinical trial. J Acquir Immune Defic Syndr 46:318-322. (Pubitemid 350287359)
-
(2007)
Journal of Acquired Immune Deficiency Syndromes
, vol.46
, Issue.3
, pp. 318-322
-
-
Wester, C.W.1
Okezie, O.A.2
Thomas, A.M.3
Bussmann, H.4
Moyo, S.5
Muzenda, T.6
Makhema, J.7
Widenfelt, E.V.8
Musonda, R.9
Novitsky, V.10
Gaolathe, T.11
Ndwapi, N.12
Essex, M.13
Kuritzkes, D.R.14
Degruttola, V.15
Marlink, R.G.16
|